Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Immunome Inc (NASDAQ: IMNM) closed at $22.33 in the last session, up 2.76% from day before closing price of $21.73. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.84 million shares were traded. IMNM stock price reached its highest trading level at $22.506 during the session, while it also had its lowest trading level at $21.56.
Ratios:
We take a closer look at IMNM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.90 and its Current Ratio is at 8.90. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Truist on December 01, 2025, initiated with a Buy rating and assigned the stock a target price of $36.
On September 22, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $26.
On September 05, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $26.Craig Hallum initiated its Buy rating on September 05, 2025, with a $26 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 22 ’25 when Barchas Isaac sold 383,200 shares for $21.74 per share. The transaction valued at 8,330,080 led to the insider holds 2,031,181 shares of the business.
SIEGALL CLAY B bought 7,278 shares of IMNM for $149,053 on Dec 19 ’25. The President and CEO now owns 860,525 shares after completing the transaction at $20.48 per share. On Dec 19 ’25, another insider, Tsai Philip, who serves as the Chief Technical Officer of the company, bought 10,000 shares for $20.49 each. As a result, the insider paid 204,900 and bolstered with 43,300 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 2463786752 and an Enterprise Value of 1779264512. For the stock, the TTM Price-to-Sale (P/S) ratio is 254.52 while its Price-to-Book (P/B) ratio in mrq is 7.76. Its current Enterprise Value per Revenue stands at 183.827 whereas that against EBITDA is -8.698.
Stock Price History:
The Beta on a monthly basis for IMNM is 2.24, which has changed by 1.1185958 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $25.30, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is 23.61%, while the 200-Day Moving Average is calculated to be 94.59%.
Shares Statistics:
According to the various share statistics, IMNM traded on average about 1.98M shares per day over the past 3-months and 4806020 shares per day over the past 10 days. A total of 110.33M shares are outstanding, with a floating share count of 101.78M. Insiders hold about 2.76% of the company’s shares, while institutions hold 79.93% stake in the company. Shares short for IMNM as of 1765756800 were 15876802 with a Short Ratio of 8.02, compared to 1763078400 on 14324512. Therefore, it implies a Short% of Shares Outstanding of 15876802 and a Short% of Float of 18.040001.
Earnings Estimates
As of right now, 11.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.46 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$1.87 and -$2.41 for the fiscal current year, implying an average EPS of -$2.2. EPS for the following year is -$2.56, with 11.0 analysts recommending between -$1.92 and -$3.52.
Revenue Estimates
A total of 12 analysts have provided revenue estimates for IMNM’s current fiscal year. The highest revenue estimate was $11M, while the lowest revenue estimate was $6.9M, resulting in an average revenue estimate of $7.77M. In the same quarter a year ago, actual revenue was $9.04M
